Delivery Order SPE2D021DA002-SPE2D324F7812
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,650.54 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 100 MG TABLET CHEW UU 60S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of the drug Isentress 400 mg Tablet, with a performance period through March 15, 2024. DMS Pharmaceutical Group Inc. holds a larger $4,999,999 indefinite delivery contract with the DLA, contract 4600082013 under the SPE2DB...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the DLA Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,861.06, is for the delivery of the pharmaceutical product Isentress 400 mg tablets. The contract has a firm fixed-price pricing type and a completion date of July 5, 2024. DMS Pharmaceutical Group Inc. holds a larger...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $16,574.04 firm-fixed-price contract is for the delivery of Isentress 400 mg tablets, a prescription pharmaceutical product. The contract has a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, SPE2DB, with the DLA valued up to $4,999,999...
- This federal contract award was granted to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,524.68 firm fixed-price delivery order contract is for the supply of ISENTRESS 400 MG TABLET to the Defense Logistics Agency (DLA) under the Medical Supply Chain division. This contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA valued up to $499,999,999, which allows the agency...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,905.85 firm fixed-price contract is for the supply of Isentress 400 mg tablets, with a period of performance through March 29, 2024. The award is issued under DMS Pharmaceutical Group's $4,999,999 indefinite delivery contract SPE2DB, which enables the...
- This federal contract award, valued at $1,381.17, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the supply of ISENTRESS 400 MG TABLET, with a period of performance through June 21, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D324F7812Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,049.36 contract provides for the delivery of Isentress 400 mg tablets to support the medical supply needs of U.S. government agencies. This order is issued against DMS Pharmaceutical Group's indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which has a ceiling value of up to $4,999,999 through 2025. Through this and other prime vendor agreements, DMS Pharmaceutical Group supplies a wide range of pharmaceutical products and medical supplies, including prescription drugs, biologics, and over-the-counter medications, to the Department of Defense and Department of Veterans Affairs. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 4/3/24 |